Shanghai Runda Med Tech Co (603108) — Capital Reinvestment Ratio
Latest as of June 2023:
0.47x
Shanghai Runda Med Tech Co (603108) has a Capital Reinvestment Ratio of 0.47x as of June 2023, meaning it reinvests 0% of its operating cash flow (CN¥144.38 Million) in capital expenditures (CN¥68.54 Million). See 603108 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.47x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥144.38 Million
CNY
Capital Expenditures
CN¥68.54 Million
CNY
Data as of
Jun 2023
Most recent filing
Shanghai Runda Med Tech Co Capital Reinvestment Ratio (2014–2024)
This chart tracks Shanghai Runda Med Tech Co's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Shanghai Runda Med Tech Co (2014–2024)
Year-by-year Capital Reinvestment Ratio for Shanghai Runda Med Tech Co from 2014 to 2024. For live market cap and broader valuation context, see market value of Shanghai Runda Med Tech Co.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.35x | CN¥646.95 Million | CN¥229.16 Million | ▼ -19.2% |
| 2023 | 0.44x | CN¥729.72 Million | CN¥319.88 Million | ▼ -46.0% |
| 2021 | 0.81x | CN¥371.11 Million | CN¥301.09 Million | ▼ -20.9% |
| 2020 | 1.03x | CN¥323.44 Million | CN¥331.94 Million | ▼ -12.3% |
| 2019 | 1.17x | CN¥246.68 Million | CN¥288.73 Million | ▲ +138.5% |
| 2018 | 0.49x | CN¥538.90 Million | CN¥264.43 Million | ▼ -85.9% |
| 2014 | 3.47x | CN¥36.11 Million | CN¥125.35 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow